A major new systematic review has added to the growing evidence that vitamin D may play a key role in the prevention and management of multiple sclerosis (MS). After examining data from 62 scientific studies, researchers found that people with MS generally have significantly lower vitamin D levels than healthy people, and that lower levels are linked to a greater risk of developing the disease and to more severe disability. The review also found that higher-dose vitamin D supplementation may help reduce relapses in some patients. These findings strengthen the case that doctors and patients need to be made more aware of the potential importance of vitamin D and other micronutrients in controlling MS.
Unreported by the mainstream/legacy media, a major scientific review published in 2025 found that coenzyme Q10 supplementation can significantly reduce systolic blood pressure, the top number in a blood pressure test, higher readings for which are strongly linked to an increased risk of heart attacks, strokes, and premature death. Analyzing 45 randomized controlled trials involving adults with a wide range of health conditions, researchers concluded that coenzyme Q10 may offer meaningful cardiovascular benefits, particularly when taken for more than eight weeks and at doses below 200 milligrams per day. The findings add to a growing body of evidence showing that micronutrients can play an important role in preventing and controlling high blood pressure and related cardiovascular problems. At a time when millions of people worldwide are struggling with hypertension despite drug treatment, the urgent need for doctors and patients to understand the potential of nutritional approaches has become impossible to ignore.
A new systematic review and meta-analysis published in the Frontiers in Nutrition journal provides important evidence that vitamin D supplementation can reduce the risk of death among critically ill adults. Analyzing 21 randomized controlled trials, the review found that supplementation significantly reduced overall mortality, with the strongest benefits seen in patients who were vitamin D deficient, those receiving doses of up to 300,000 IU, and those given vitamin D by injection. The findings provide further evidence that doctors need to begin taking nutritional support as seriously as they do drugs, surgery, and other standard medical treatments.
Can Higher Doses of Magnesium Thwart Epilepsy?
There may be a connection between increased dietary magnesium intake and reducing incidence of epilepsy, new research suggests.